One-Day Use of Preoperative Topical Nonsteroidal Anti-Inflammatory Drug Prevents Intraoperative Prostaglandin Level Elevation During Femtosecond Laser-Assisted Cataract Surgery

References

• Nagy ZZ, Takacs AI, Filkorn T, Sarayba M. Initial clinical evaluation of an intraocular femtosecond laser in cataract surgery. J Refract Surg 2009;25(12):1053–1060.
   PubMed Web of Science ®Google Scholar
• Nagy ZZ. New technology update: femtosecond laser in cataract surgery. Clin Ophthalmol 2014;8:1157–1167.
   PubMedGoogle Scholar
• He L, Sheehy K, Culbertson W. Femtosecond laser-assisted cataract surgery. Curr Opin Ophthalmol 2011;22(1):43–52.
   PubMed Web of Science ®Google Scholar
• Schultz T, Joachim SC, Kuehn M, Dick HB. Changes in prostaglandin levels in patients undergoing femtosecond laser-assisted cataract surgery. J Refract Surg 2013;29(11):742–747.
   PubMed Web of Science ®Google Scholar
• Schultz T, Joachim SC, Stellbogen M, Dick HB. Prostaglandin release during femtosecond laser-assisted cataract surgery: main inducer. J Refract Surg 2015;31(2):78–81.
   PubMed Web of Science ®Google Scholar
• Lindstrom R, Kim T. Ocular permeation and inhibition of retinal inflammation: an examination of data and expert opinion on the clinical utility of nepafenac. Curr Med Res Opin 2006;22(2):397–404.
   PubMed Web of Science ®Google Scholar
• Bucci FA, Waterbury LD, Amico LM. Prostaglandin E2 inhibition and aqueous concentration of ketorolac 0.4% (acular LS) and nepafenac 0.1% (nevanac) in patients undergoing phacoemulsification. Am J Ophthalmol 2007;144(1):146–147.
   PubMed Web of Science ®Google Scholar
• Walters T, Raizman M, Ernest P, Gayton J, Lehmann R. In vivo pharmacokinetics and in vitro pharmacodynamics of nepafenac, amfenac, ketorolac, and bromfenac. J Cataract Refract Surg 2007;33(9):1539–1545.
   PubMed Web of Science ®Google Scholar
• Bucci FA, Waterbury LD. Prostaglandin E2 inhibition of ketorolac 0.45%, bromfenac 0.09%, and nepafenac 0.1% in patients undergoing phacoemulsification. Adv Ther 2011;28(12):1089–1095.
   PubMed Web of Science ®Google Scholar
• Rosner M, Gelerstein S, Weissman C, Naveh N. Prostaglandin E2 and protein levels in rabbit aqueous humor following ND:YAG laser iridotomy. Metab Pediatr Syst Ophthalmol 1988;11(1–2):50–52.
   Google Scholar
• Nishi O, Nishi K, Imanishi M. Synthesis of interleukin-1 and prostaglandin E2 by lens epithelial cells of human cataracts. Br J Ophthalmol 1992;76(6):338–341.
   PubMed Web of Science ®Google Scholar
• Sivaprasad S, Bunce C, Crosby-Nwaobi R. Non-steroidal anti-inflammatory agents for treating cystoid macular oedema following cataract surgery. Cochrane Database Syst Rev 2012;2:CD004239.
   PubMed Web of Science ®Google Scholar
• Henderson BA, Kim JY, Ament CS, Ferrufino-Ponce ZK, Grabowska A, Cremers SL. Clinical pseudophakic cystoid macular edema. Risk factors for development and duration after treatment. J Cataract Refract Surg 2007;33(9):1550–1558.
   PubMed Web of Science ®Google Scholar
• Loewenstein A, Zur D. Postsurgical cystoid macular edema. Dev Ophthalmol 2010;47:148–159.
   PubMedGoogle Scholar
• Perente I, Utine CA, Ozturker C, Cakir M, Kaya V, Eren H, et al. Evaluation of macular changes after uncomplicated phacoemulsification surgery by optical coherence tomography. Curr Eye Res 2007;32(3):241–247.
   PubMed Web of Science ®Google Scholar
• Biro Z, Balla Z, Kovacs B. Change of foveal and perifoveal thickness measured by OCT after phacoemulsification and IOL implantation. Eye (Lond) 2008;22(1):8–12.
   PubMed Web of Science ®Google Scholar
• von Jagow B, Ohrloff C, Kohnen T. Macular thickness after uneventful cataract surgery determined by optical coherence tomography. Graefes Arch Clin Exp Ophthalmol 2007;245(12):1765–1771.
   PubMed Web of Science ®Google Scholar
• Conrad-Hengerer I, Hengerer FH, Al Juburi M, Schultz T, Dick HB. Femtosecond laser-induced macular changes and anterior segment inflammation in cataract surgery. J Refract Surg 2014;30(4):222–226.
   PubMed Web of Science ®Google Scholar
• Ecsedy M, Miháltz K, Kovács I, Takács A, Filkorn T, Nagy ZZ. Effect of femtosecond laser cataract surgery on the macula. J Refract Surg 2011;27(10):717–722.
   PubMed Web of Science ®Google Scholar
• Nagy ZZ, Ecsedy M, Kovács I, Takács Á, Tátrai E, Somfai GM, et al. Macular morphology assessed by optical coherence tomography image segmentation after femtosecond laser-assisted and standard cataract surgery. J Cataract Refract Surg 2012;38(6):941–946.
   PubMed Web of Science ®Google Scholar
• Nagy ZZ, Takacs AI, Filkorn T, Kránitz K, Gyenes A, Juhász É, et al. Complications of femtosecond laser-assisted cataract surgery. J Cataract Refract Surg 2014;40(1):20–28.
   PubMed Web of Science ®Google Scholar
• Roberts CW. Pretreatment with topical diclofenac sodium to decrease postoperative inflammation. Ophthalmology 1996;103(4):636–639.
   PubMed Web of Science ®Google Scholar
• Kessel L, Tendal B, Jørgensen KJ, Erngaard D, Flesner P, Andresen JL, et al. Post-cataract prevention of inflammation and macular edema by steroid and nonsteroidal anti-inflammatory eye drops: a systematic review. Ophthalmology 2014;121(10):1915–1924.
   PubMed Web of Science ®Google Scholar
• Jones BM, Neville MW. Nepafenac: an ophthalmic nonsteroidal antiinflammatory drug for pain after cataract surgery. Ann Pharmacother 2013;47(6):892–896.
   PubMed Web of Science ®Google Scholar
• Almeida DR, Khan Z, Xing L, Bakar SN, Rahim K, Urton T, et al. Prophylactic nepafenac and ketorolac versus placebo in preventing postoperative macular edema after uneventful phacoemulsification. J Cataract Refract Surg 2012;38(9):1537–1543.
   PubMed Web of Science ®Google Scholar
• Bekendam PD, Narváez J, Agarwal M. Case of corneal melting associated with the use of topical nepafenac. Cornea 2007;26(8):1002–1003.
   PubMed Web of Science ®Google Scholar
• Wolf EJ, Kleiman LZ, Schrier A. Nepafenac-associated corneal melt. J Cataract Refract Surg 2007;33(11):1974–1975.
   PubMed Web of Science ®Google Scholar
• Di Pascuale MA, Whitson JT, Mootha VV. Corneal melting after use of nepafenac in a patient with chronic cystoid macular edema after cataract surgery. Eye Contact Lens 2008;34(2):129–130.
   PubMed Web of Science ®Google Scholar
• Feiz V, Oberg TJ, Kurz CJ, Mamalis N, Moshirfar M. Nepafenac-associated bilateral corneal melt after photorefractive keratectomy. Cornea 2009;28(8):948–950.
   PubMed Web of Science ®Google Scholar
• O’Brien TP. Emerging guidelines for use of NSAID therapy to optimize cataract surgery patient care. Curr Med Res Opin 2005;21(7):1131–1137.
   PubMed Web of Science ®Google Scholar
• Scholl S, Kirchhof J, Augustin AJ. Pathophysiology of macular edema. Ophthalmologica 2010;224(Suppl 1):8–15.
   PubMedGoogle Scholar